BIO-TECHNE CORP (TECH) Stock Fundamental Analysis

NASDAQ:TECH • US09073M1045

55.01 USD
-2.51 (-4.36%)
Last: Feb 23, 2026, 11:03 AM
Fundamental Rating

6

Taking everything into account, TECH scores 6 out of 10 in our fundamental rating. TECH was compared to 58 industry peers in the Life Sciences Tools & Services industry. TECH scores excellent points on both the profitability and health parts. This is a solid base for a good stock. TECH is not valued too expensively and it also shows a decent growth rate. This makes TECH very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year TECH was profitable.
  • TECH had a positive operating cash flow in the past year.
  • In the past 5 years TECH has always been profitable.
  • Each year in the past 5 years TECH had a positive operating cash flow.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.17%, TECH is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
  • TECH's Return On Equity of 3.98% is fine compared to the rest of the industry. TECH outperforms 74.14% of its industry peers.
  • TECH's Return On Invested Capital of 9.52% is amongst the best of the industry. TECH outperforms 87.93% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for TECH is below the industry average of 11.94%.
  • The last Return On Invested Capital (9.52%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.17%
ROE 3.98%
ROIC 9.52%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • TECH has a better Profit Margin (6.58%) than 74.14% of its industry peers.
  • In the last couple of years the Profit Margin of TECH has declined.
  • TECH has a better Operating Margin (22.59%) than 93.10% of its industry peers.
  • In the last couple of years the Operating Margin of TECH has remained more or less at the same level.
  • TECH has a better Gross Margin (66.60%) than 87.93% of its industry peers.
  • In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
Industry RankSector Rank
OM 22.59%
PM (TTM) 6.58%
GM 66.6%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TECH is destroying value.
  • TECH has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TECH has been increased compared to 5 years ago.
  • The debt/assets ratio for TECH is higher compared to a year ago.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • TECH has an Altman-Z score of 12.24. This indicates that TECH is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of TECH (12.24) is better than 96.55% of its industry peers.
  • The Debt to FCF ratio of TECH is 1.17, which is an excellent value as it means it would take TECH, only 1.17 years of fcf income to pay off all of its debts.
  • TECH has a better Debt to FCF ratio (1.17) than 89.66% of its industry peers.
  • TECH has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.13, TECH is in the better half of the industry, outperforming 60.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.17
Altman-Z 12.24
ROIC/WACC0.88
WACC10.85%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • TECH has a Current Ratio of 4.54. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
  • TECH's Current ratio of 4.54 is fine compared to the rest of the industry. TECH outperforms 72.41% of its industry peers.
  • A Quick Ratio of 3.08 indicates that TECH has no problem at all paying its short term obligations.
  • The Quick ratio of TECH (3.08) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 3.08
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 8.84% over the past year.
  • Measured over the past years, TECH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.25% on average per year.
  • TECH shows a small growth in Revenue. In the last year, the Revenue has grown by 1.64%.
  • TECH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%

3.2 Future

  • TECH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.61% yearly.
  • The Revenue is expected to grow by 7.10% on average over the next years.
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

  • TECH is valuated quite expensively with a Price/Earnings ratio of 27.92.
  • Based on the Price/Earnings ratio, TECH is valued a bit cheaper than 63.79% of the companies in the same industry.
  • TECH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • TECH is valuated rather expensively with a Price/Forward Earnings ratio of 24.50.
  • 68.97% of the companies in the same industry are more expensive than TECH, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.02. TECH is around the same levels.
Industry RankSector Rank
PE 27.92
Fwd PE 24.5
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as TECH.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 63.79% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 38.59
EV/EBITDA 24.01
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
  • TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6
PEG (5Y)2.48
EPS Next 2Y7.87%
EPS Next 3Y10.61%

4

5. Dividend

5.1 Amount

  • TECH has a yearly dividend return of 0.54%, which is pretty low.
  • TECH's Dividend Yield is rather good when compared to the industry average which is at 0.10. TECH pays more dividend than 94.83% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, TECH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

  • The dividend of TECH has a limited annual growth rate of 0.11%.
  • TECH has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of TECH decreased recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

  • TECH pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.38%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

BIO-TECHNE CORP

NASDAQ:TECH (2/23/2026, 11:03:56 AM)

55.01

-2.51 (-4.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners107.49%
Inst Owner Change4.03%
Ins Owners0.25%
Ins Owner Change1.58%
Market Cap8.61B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts81.74
Price Target71.44 (29.87%)
Short Float %6.31%
Short Ratio4.54
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)0%
PT rev (3m)5.24%
EPS NQ rev (1m)-3.7%
EPS NQ rev (3m)-4.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)-1.44%
Revenue NQ rev (3m)-1.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 27.92
Fwd PE 24.5
P/S 7.08
P/FCF 38.59
P/OCF 34.52
P/B 4.28
P/tB 12.38
EV/EBITDA 24.01
EPS(TTM)1.97
EY3.58%
EPS(NY)2.25
Fwd EY4.08%
FCF(TTM)1.43
FCFY2.59%
OCF(TTM)1.59
OCFY2.9%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)6
PEG (5Y)2.48
Graham Number23.87
Profitability
Industry RankSector Rank
ROA 3.17%
ROE 3.98%
ROCE 11.53%
ROIC 9.52%
ROICexc 10.26%
ROICexgc 25.36%
OM 22.59%
PM (TTM) 6.58%
GM 66.6%
FCFM 18.35%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.17
Debt/EBITDA 0.69
Cap/Depr 25.35%
Cap/Sales 2.16%
Interest Coverage 15.32
Cash Conversion 65.89%
Profit Quality 278.92%
Current Ratio 4.54
Quick Ratio 3.08
Altman-Z 12.24
F-Score8
WACC10.85%
ROIC/WACC0.88
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year15.61%
EBIT Next 3Y13.34%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status of BIO-TECHNE CORP (TECH) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.


How profitable is BIO-TECHNE CORP (TECH) stock?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


What is the financial health of BIO-TECHNE CORP (TECH) stock?

The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.


Is the dividend of BIO-TECHNE CORP sustainable?

The dividend rating of BIO-TECHNE CORP (TECH) is 4 / 10 and the dividend payout ratio is 62.38%.